“With the successful launch of our fourth and final clinical trial site in the USA; we’ve reached a
significant milestone in our development program. This momentum reflects our unwavering
commitment to advancing cell therapy and positions us to deliver meaningful value to both
patients and shareholders,” said Dr Rebecca McQualter, Chimeric Therapeutics’ Chief Executive
Officer.
I agree, that should speed up the trials a bit as the initial preparations are always a bit tricky. But once set up it should go a bit faster.
Let's hope for sufferers and you holders.
“With the successful launch of our fourth and final clinical...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
-0.001(12.5%) |
Mkt cap ! $12.99M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.4¢ | 0.3¢ | $10.43K | 3.475M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 72 | 70146076 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 84897305 | 25 |
View Market Depth
| Last trade - 10.14am 31/07/2025 (20 minute delay) ? |
| CHM (ASX) Chart |